Physician profile
Olivia V Smith
NPI 1801526769
$608.08
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.42 · 2023: $476 · 2024: $59.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $115.54 | 2023-2024 | |
| Novo Nordisk INC | $86.24 | 2023 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $69.31 | 2023-2024 | Farxiga |
| Pfizer INC. | $64.68 | 2023 | |
| Lilly USA, LLC | $63.00 | 2023 | Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $55.96 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $49.55 | 2022-2023 | M-M-R II, Gardasil 9, Varivax |
| Teva Pharmaceuticals USA, INC. | $38.81 | 2022 | |
| Hologic Sales and Service, LLC | $27.82 | 2023 | Aptima |
| Exact Sciences Corporation | $20.57 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $16.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.